Alfred Clinical Trials

Alfred Health has more than 700 open trials across 20 clinical disciplines, our clinical trial portfolio is one of the largest in the country.

Clear filter
604 clinical trials found
Clinical trials

HOME-AKI

HOME-AKI: Haemofiltration with Oxiris: Multicentre Evaluation in Acute Kidney Injury (U1111-1247-3435)

Currently recruiting

H-MEET

Home-based Minimal Equipment Exercise Training (H-MEET) delivered using remote supervision: A randomised controlled feasibility study (ACTRN12625000550404)

Currently recruiting

DCD-HOPE

Hypothermic Oxygenated Perfusion (HOPE) in Donation after Circulatory Death (DCD) for Heart Transplantation (Registration Pending)

Coming soon

IDE196-002

IDE196 (DAROVASERTIB) IN COMBINATION WITH CRIZOTINIB VERSUS INVESTIGATOR’S CHOICE OF TREATMENT AS FIRST-LINE THERAPY IN HLA-A2 NEGATIVE METASTATIC UVEAL MELANOMA (DAR-UM-2) (NCT05987332)

Currently recruiting

Lung Tx - Biomarker III

IDENTIFYING IMMUNE AND INFECTIOUS BIOMARKERS OF EARLY AND LATE ALLOGRAFT DYSFUNCTION FOLLOWING LUNG TRANSPLANTATION (Trial Not Registered)

Currently recruiting

FDED001

Imaging Astrogliosis in Patients with Epilepsy with [18F]-FDED PET (ACTRN12625000170426)

Currently recruiting

The TA Trial

Impact of Total Arterial Revascularisation in Coronary Artery Surgery on Angiographic and Clinical Outcomes (ACTRN12623000864628)

Currently recruiting

IMPAHCT

IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in patients with Pulmonary Arterial Hypertension (PAH). (NCT05036135)

Currently recruiting

EXTEND-IA DNase

Improving early reperfusion with adjuvant dornase alfa in large vessel ischemic stroke (NCT05203224)

Currently recruiting

RPC01-3201

INDUCTION STUDY #1 - A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND,PLACEBO-CONTROLLED STUDY OF ORAL OZANIMOD AS INDUCTION THERAPY FOR MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE (NCT03440372)

Currently recruiting

E-nside INNER-B-APAC

INNER-B-APAC – Asian Pacific post-market clinical follow-up study in patients with thoracoabdominal aortic aneurysms treated with E-nside TAAA Multibranch Stent Graft System (NCT05954793)

Currently recruiting

INFORMED-1

Integrative approaches for Optimizing Recognition, Management and Education of concussion at the community sports level (ACTRN12623000554662)

Currently recruiting

INTENT

Intensive nutrition therapy compared to usual care in critically ill adults: A randomised pilot trial (NCT03292237)

Recently completed/closed

IRONMAN

International Registry for Men with Advanced Prostate Cancer (IRONMAN) (NCT03151629)

Currently recruiting

20007A

Interventional, randomized, double-blind, parallel-group, placebo-controlled study of add-on eptinezumab treatment to brief educational intervention for the preventive treatment of migraine in patients with dual diagnosis of migraine and medication overuse headache (NCT05452239)

Currently recruiting

INSPIRE

Invasive assessment of pulmonary microvascular function with novel indices of pulmonary flow reserve and pulmonary microcirculatory resistance. (Trial Not Registered)

Currently recruiting

EFFECT

Investigating the immunomodulatory and clinical effects of fermentable fibre intervention to reduce symptoms of Long COVID (ACTRN12624000356561)

Currently recruiting

ITACS

IV iron for Treatment of Anaemia before Cardiac Surgery (NCT02632760)

Currently recruiting

KIBI

Ketamine Sedation in Acute Traumatic Brain Injury: A Randomised Pilot Feasibility Study (ACTRN12623000594628)

Currently recruiting

ENDURE-AF

Left Atrial Posterior Wall Isolation VS Left Atrial Posterior Wall isolation and Superior Vena Cava Isolation and Cavo-tricuspid isthmus Isolation and Mitral Isthmus Isolation for Recurrent Atrial Fibrillation Post Pulmonary Vein Isolation – A Randomised Control Trial (The ENDURE-AF randomised control trial) (ACTRN12624000676516)

Coming soon
22 23 24 25 26